2 results
Approved WMOCompleted
Primary Objectives* To compare the pathologic complete response (pCR) rate of neoadjuvant nivolumab + NKTR-214 to Standard of Care (SOC, no neoadjuvant therapy) in all randomized participants* To compare the event-free survival (EFS) of neoadjuvant…
Approved WMOCompleted
In this study, we will investigate how quickly and to what extent the investigational medicinal product pritelivir is absorbed, transported, and eliminated from the body (this is called pharmacokinetics). In addition, we will evaluate a possible…